Cell MedX Corp. (CMXC)

USD 0.43

(N/A%)

Long Term Debt Summary of Cell MedX Corp.

  • Cell MedX Corp.'s latest annual long term debt in 2024 was - USD , down 0.0% from previous year.
  • Cell MedX Corp.'s latest quarterly long term debt in 2024 FY was - USD , down 0.0% from previous quarter.
  • Cell MedX Corp. reported annual long term debt of - USD in 2023, down 0.0% from previous year.
  • Cell MedX Corp. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • Cell MedX Corp. reported quarterly long term debt of - USD for 2024 FY, down 0.0% from previous quarter.
  • Cell MedX Corp. reported quarterly long term debt of - USD for 2024 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Cell MedX Corp. (2024 - 2011)

Historical Annual Long Term Debt of Cell MedX Corp. (2024 - 2011)

Year Long Term Debt Long Term Debt Growth
2024 - USD 0.0%
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Long Term Debt Comparison of Cell MedX Corp.

Name Long Term Debt Long Term Debt Difference
Acutus Medical, Inc. 32.65 Million USD 100.0%
Biotricity, Inc. 10.85 Million USD 100.0%
Dynatronics Corporation 3.25 Million USD 100.0%
Nemaura Medical Inc. 3.08 Million USD 100.0%
PetVivo Holdings, Inc. 1.01 Million USD 100.0%
RetinalGenix Technologies Inc. - USD NaN%
Sonendo, Inc. 14.03 Million USD 100.0%
Telesis Bio, Inc. 5.26 Million USD 100.0%
Talis Biomedical Corporation 16.78 Million USD 100.0%
Viveve Medical, Inc. 5.12 Million USD 100.0%